Fish oil for primary and secondary prevention of coronary heart disease

Eli M. Roth; William S. Harris

doi:10.1007/s11883-009-0079-6

Fish oil for primary and secondary prevention of coronary heart disease

Eli M. Roth, William S. Harris

Research output: Contribution to journal › Review article › peer-review

60 Scopus citations

Abstract

Fish consumption and fish oils rich in omega-3 fatty acids were reported to be cardioprotective in both retrospective and prospective studies undertaken over the past two to three decades. In the past several years, there is mounting clinical trial data as well as basic science information supporting the use of fish oil supplements in both primary and secondary cardiovascular prevention. In addition, there appear to be additional benefits to the use of fish oil, including lowering significantly elevated triglyceride levels, preventing atrial fibrillation, reducing mortality rates in congestive heart failure patients, and perhaps stabilizing atherosclerotic plaques. These data have led to specific recommendations for use of omega-3 fatty acids in several cardiovascular areas.

Original language	English (US)
Pages (from-to)	66-72
Number of pages	7
Journal	Current atherosclerosis reports
Volume	12
Issue number	1
DOIs	https://doi.org/10.1007/s11883-009-0079-6
State	Published - Jan 2010
Externally published	Yes

Keywords

DHA
EPA
Fish oil
Omega-3 fatty acid
Primary & secondary cardiovascular prevention

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11883-009-0079-6

Cite this

@article{649e7cd251d24f038271fd2844d02d77,

title = "Fish oil for primary and secondary prevention of coronary heart disease",

abstract = "Fish consumption and fish oils rich in omega-3 fatty acids were reported to be cardioprotective in both retrospective and prospective studies undertaken over the past two to three decades. In the past several years, there is mounting clinical trial data as well as basic science information supporting the use of fish oil supplements in both primary and secondary cardiovascular prevention. In addition, there appear to be additional benefits to the use of fish oil, including lowering significantly elevated triglyceride levels, preventing atrial fibrillation, reducing mortality rates in congestive heart failure patients, and perhaps stabilizing atherosclerotic plaques. These data have led to specific recommendations for use of omega-3 fatty acids in several cardiovascular areas.",

keywords = "DHA, EPA, Fish oil, Omega-3 fatty acid, Primary & secondary cardiovascular prevention",

author = "Roth, {Eli M.} and Harris, {William S.}",

year = "2010",

month = jan,

doi = "10.1007/s11883-009-0079-6",

language = "English (US)",

volume = "12",

pages = "66--72",

journal = "Current Atherosclerosis Reports",

issn = "1523-3804",

publisher = "Current Medicine Group",

number = "1",

}

TY - JOUR

T1 - Fish oil for primary and secondary prevention of coronary heart disease

AU - Roth, Eli M.

AU - Harris, William S.

PY - 2010/1

Y1 - 2010/1

N2 - Fish consumption and fish oils rich in omega-3 fatty acids were reported to be cardioprotective in both retrospective and prospective studies undertaken over the past two to three decades. In the past several years, there is mounting clinical trial data as well as basic science information supporting the use of fish oil supplements in both primary and secondary cardiovascular prevention. In addition, there appear to be additional benefits to the use of fish oil, including lowering significantly elevated triglyceride levels, preventing atrial fibrillation, reducing mortality rates in congestive heart failure patients, and perhaps stabilizing atherosclerotic plaques. These data have led to specific recommendations for use of omega-3 fatty acids in several cardiovascular areas.

AB - Fish consumption and fish oils rich in omega-3 fatty acids were reported to be cardioprotective in both retrospective and prospective studies undertaken over the past two to three decades. In the past several years, there is mounting clinical trial data as well as basic science information supporting the use of fish oil supplements in both primary and secondary cardiovascular prevention. In addition, there appear to be additional benefits to the use of fish oil, including lowering significantly elevated triglyceride levels, preventing atrial fibrillation, reducing mortality rates in congestive heart failure patients, and perhaps stabilizing atherosclerotic plaques. These data have led to specific recommendations for use of omega-3 fatty acids in several cardiovascular areas.

KW - DHA

KW - EPA

KW - Fish oil

KW - Omega-3 fatty acid

KW - Primary & secondary cardiovascular prevention

UR - http://www.scopus.com/inward/record.url?scp=77149160605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77149160605&partnerID=8YFLogxK

U2 - 10.1007/s11883-009-0079-6

DO - 10.1007/s11883-009-0079-6

M3 - Review article

C2 - 20425273

AN - SCOPUS:77149160605

SN - 1523-3804

VL - 12

SP - 66

EP - 72

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

IS - 1

ER -

Fish oil for primary and secondary prevention of coronary heart disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this